Study: Integrated Intervention Increases Use of HIV Therapy in Critical Population – APhA submits compounding comments to FDA.

29960_pharmacyboard_standard_081816Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Study: Integrated Intervention Increases Use of HIV Therapy in Critical Population – APhA submits compounding comments to FDA. – (866) 348-2889.

People who inject drugs (PWID) are a critical population that are at a higher risk of being infected with HIV. According to the CDC, HIV can survive in a used needle for up to 42 days, depending on temperatures and other factors.

In a new study, which focused on the PWID population in multiple study sites, investigators used intervention programs where participants received referrals for HIV management and medication along with harm-reduction packages, HIV testing and counseling, referrals for antiretroviral therapy, and eduation about basic HIV treatment in an effort to improve patient outcomes. The investigators concluded that the interventions actually increased use of antiretroviral (ART) medication use by 30%.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.